DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Ji L, Dong X, Li Y. et al
Efficacy and safety of once-weekly semaglutide vs once-daily sitagliptin as
add-on to metformin in patients with type 2 diabetes (SUSTAIN China): a
30–week double-blind, phase 3a, randomised trial.
Diabetes, Obesity and Metabolism 2021;
23: 404-414
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.